STOCK TITAN

HEXO Corp. Announces Proposed Public Offering

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

HEXO Corp (TSX: HEXO; NYSE: HEXO) has announced its intent to file a preliminary prospectus supplement for an overnight marketed public offering of units. The offering's pricing and final terms are to be determined, with a potential additional 15% over-allotment option for underwriters. Proceeds will partially fund the Redecan acquisition and support HEXO's U.S. expansion plans. The offering is subject to market conditions and regulatory approvals.

Positive
  • Proceeds from the offering will support the cash component of the Redecan acquisition.
  • Funds will also facilitate HEXO's U.S. expansion plans.
Negative
  • The offering may lead to shareholder dilution.
  • Market uncertainty may affect the completion and terms of the offering.

OTTAWA, Aug. 19, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it will be filing a preliminary prospectus supplement (the "Preliminary Supplement") to its amended and restated short form base shelf prospectus dated May 25, 2021 (the "Base Shelf Prospectus") relating to a proposed overnight marketed public offering (the "Offering") of units of the Company (the "Units").

The Offering is expected to be priced in the context of the market, with the final terms of the Offering to be determined at the time of pricing. There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering. The closing of the Offering will be subject to market and other customary conditions, including approvals of the Toronto Stock Exchange.

In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the Units offered in the proposed Offering on the same terms and conditions.

The Company expects to use the net proceeds from the Offering to satisfy a portion of the cash component of the purchase price payable to the Redecan shareholders on closing of the Redecan acquisition and for expenditures in relation to the Company’s U.S. expansion plans.

A.G.P./Alliance Global Partners and Cantor Fitzgerald Canada Corporation are acting as joint bookrunners for the Offering.

The Preliminary Supplement will be filed with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada, and with the U.S. Securities and Exchange Commission (the "SEC") as part of the Company's registration statement on Form F-10 (the "Registration Statement") under the U.S./Canada Multijurisdictional Disclosure System ("MJDS"). The Preliminary Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the proposed Offering. Prospective investors should read the Preliminary Supplement, the Base Shelf Prospectus and the Registration Statement and the other documents the Company has filed before making an investment decision.

Copies of the Preliminary Supplement, following filing thereof, and the Base Shelf Prospectus will be available on SEDAR at www.sedar.com and copies of the Preliminary Supplement and the Registration Statement will be available on EDGAR at www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com. Copies of the prospectus supplement may also be obtained, when available, from Cantor Fitzgerald Canada Corporation in Canada, by emailing ecmcanada@cantor.com, or Cantor Fitzgerald & Co. in the U.S., by emailing prospectus@cantor.com.

No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About HEXO Corp (TSX: HEXO; NYSE: HEXO)

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.

Forward Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws ("forward-looking statements"), including statements regarding the terms, timing and potential completion of, and use of proceeds from, the Offering. Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements, including that the Offering may not be completed on the terms indicated or at all, the Company may be unsuccessful in satisfying the conditions to closing of the Offering and the Company's use of proceeds of the Offering may differ from those indicated. Forward -looking statements should not be read as guarantees of future performance or results.

A more complete discussion of the risks and uncertainties facing the Company appears in the Preliminary Supplement, the Base Shelf Prospectus and the Registration Statement and in the Company's Annual Information Form and other continuous disclosure filings, which are available on SEDAR at www.sedar.com and EDGAR at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:

invest@HEXO.com 

www.hexocorp.com 

 
Media Relations:

(819) 317-0526

media@hexo.com 


FAQ

What is HEXO planning with its public offering?

HEXO intends to raise funds through a public offering to partially finance the Redecan acquisition and support its U.S. expansion.

What are the terms of HEXO's public offering?

The final terms of the offering are yet to be determined, with a possibility of a 15% over-allotment option for underwriters.

How will HEXO's public offering affect shareholders?

The public offering may lead to shareholder dilution, depending on the final number of units issued.

When will HEXO's public offering be completed?

The completion of the offering is subject to market conditions and regulatory approvals, and no assurance can be provided regarding its timing.

Where can I find more information about HEXO's public offering?

More information can be found in the preliminary prospectus supplement and other related documents available on SEDAR and EDGAR.

HEXO

NASDAQ:HEXO

HEXO Rankings

HEXO Latest News

HEXO Stock Data

31.24M
42.86M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Ottawa